| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |